XML 46 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
Market Concentrations
 12 Months Ended
Dec. 31, 2011
Market Concentrations [Abstract]  
Market Concentrations
(14) Market Concentrations

The Company currently focuses on acquiring, developing, and commercializing branded prescription products for the acute care and gastroenterology markets. The Company’s principal financial instruments subject to potential concentration of credit risk are accounts receivable, which are unsecured, and cash equivalents. The Company’s cash equivalents consist primarily of money market funds. Certain bank deposits may at times be in excess of the Federal Deposit Insurance Corporation (FDIC) insurance limits.

 

The Company’s primary customers are wholesale pharmaceutical distributors in the U.S. Total revenues from customers representing 10% or more of total revenues for the respective years are summarized as follows:

 

      September 30,       September 30,       September 30,  
    2011     2010     2009  
       

Customer 1

     36 %      35 %      37 % 

Customer 2

     28       31       29  

Customer 3

     31       26       27  

Additionally, 95% and 80% of the Company’s accounts receivable balances were due from these three customers at December 31, 2011 and 2010, respectively.